Waning immunity after receipt of pertussis, diphtheria, tetanus, and polio-related vaccines: A systematic review and meta-analysis

H Gao, EHY Lau, BJ Cowling - The Journal of Infectious …, 2022 - academic.oup.com
Pertussis, diphtheria, and tetanus (DTP)–containing vaccines combined with polio vaccines
are recommended by the World Health Organization as part of routine immunization …

A call for caution in use of pertussis vaccine effectiveness studies to estimate waning immunity: a Canadian Immunization Research Network Study

NS Crowcroft, KL Schwartz, RD Savage… - Clinical Infectious …, 2021 - academic.oup.com
Background Vaccine effectiveness (VE) studies provide essential evidence on waning
vaccine-derived immunity, a major threat to pertussis control. We evaluated how study …

Primary vaccination of adults with reduced antigen-content diphtheria-tetanus-acellular pertussis or dTpa-inactivated poliovirus vaccines compared to diphtheria …

H Theeten, H Rümke, FJP Hoppener… - … medical research and …, 2007 - Taylor & Francis
Objective: To evaluate immunogenicity and reactogenicity of primary vaccination with
reduced-antigen-content diphtheria-tetanus-acellular pertussis (dTpa) or dTpa-inactivated …

Effectiveness of pertussis vaccination and duration of immunity

KL Schwartz, JC Kwong, SL Deeks, MA Campitelli… - Cmaj, 2016 - Can Med Assoc
Background: A resurgence of pertussis cases among both vaccinated and unvaccinated
people raises questions about vaccine effectiveness over time. Our objective was to study …

Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV; Repevax®) administered …

U Zimmermann, G Gavazzi, P Richard, C Eymin… - Vaccine, 2013 - Elsevier
BACKGROUND: Annual influenza vaccination provides an opportunity to administer a
booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine …

Duration of pertussis immunity after DTaP immunization: a meta-analysis

A McGirr, DN Fisman - Pediatrics, 2015 - publications.aap.org
BACKGROUND AND OBJECTIVES: Pertussis incidence is increasing, possibly due to the
introduction of acellular vaccines, which may have decreased the durability of immune …

Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in …

R Koepke, JC Eickhoff, RA Ayele… - The Journal of …, 2014 - academic.oup.com
Background. We estimated the vaccine effectiveness (VE) of tetanus-diphtheria-acellular
pertussis vaccine (Tdap) for preventing pertussis among adolescents during a statewide …

Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous dose

SA Halperin, D Scheifele, G De Serres, F Noya… - Vaccine, 2012 - Elsevier
BACKGROUND: Although decennial adult boosters of tetanus and diphtheria toxoids are
recommended in Canada and the United States, a second dose of pertussis vaccine during …

Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial

J Beytout, O Launay, N Guiso, A Fiquet, M Baudin… - Human …, 2009 - Taylor & Francis
Background: In France, the only vaccines available for use as a pertussis booster in adults
are combined vaccines containing adsorbed tetanus, diphtheria (adult formulation), acellular …

Duration of immunity against pertussis after natural infection or vaccination

AM Wendelboe, A Van Rie, S Salmaso… - The Pediatric …, 2005 - journals.lww.com
Despite decades of high vaccination coverage, pertussis has remained endemic and
reemerged as a public health problem in many countries in the past 2 decades. Waning of …